Linden Thomson

Linden has over 12 years of experience in medical and biotechnology investing, including 5 years as an equity analyst at Goldman Sachs, before moving to the buy side where she worked as a pharmaceutical and technology analyst at the hedge fund Clear River Capital and finally to her current role at AXA. Linden is a CFA Charterholder and has a Bachelor’s degree in Medical Microbiology.

Manages these EQ rated funds
Fund EQ model portfolios holding this fund
AXA Framlington BiotechNot currently held in our model portfolios
See all our rated funds

Investing with EQ

EQ offers a choice of investment strategies. We use these strategies to build and manage individual portfolios of investments for our clients:

Best Ideas

Best Ideas

Our signature portfolios invest in the very best ideas unearthed by our research team, unconstrained across all asset types.
Low Cost

Low Cost

The name says it all. These portfolios invest mainly in low cost funds that track the performance of stockmarket indices.
Positive Impact

Positive Impact

Not just good investments, but investments that do good. These portfolios are carefully screened for social and environmental impact.
Income

Income

These portfolios have been designed for those investors who have begun to withdraw fundfs from their portfolios.